23May 2023
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States

Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States

An outbreak of mpox (formerly known as monkeypox) disproportionately affected transgender persons and men who have sex with men in the United States. The JYNNEOS vaccine was approved for preventing mpox in 2019. A case-control study using electronic health record data was conducted to assess the vaccine's effectiveness. The study found that receiving two doses of the vaccine provided 66.0% effectiveness in preventing medically attended mpox, while one dose provided 35.8% effectiveness. The study concluded that the JYNNEOS vaccine was effective in preventing mpox, with better protection observed with a two-dose series.

  • #family health

Like

Save

Share